Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Cancer Discov. 2020 Jan 10;10(4):526–535. doi: 10.1158/2159-8290.CD-19-1209

Figure 1.

Figure 1.

Figure 1.

Figure 1.

Overall survival by AKT1 mutation status. (A) Time from metastatic diagnosis to death or last follow-up, as well as tumor sequencing*; (B) Overall survival using left truncation; (C) Overall survival without left truncation.

*5 patients underwent tumor sequencing before their metastatic diagnosis